-
1
-
-
79251605368
-
-
FDA, U.S. Food and Drug Administration. Accessed 05 March 2010
-
FDA, U.S. Food and Drug Administration (2009) http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm112669.htm. Accessed 05 March 2010
-
(2009)
-
-
-
2
-
-
45149118311
-
-
1:CAS:528:DC%2BD1cXmvVCisrY%3D 10.1038/nbt1407
-
M Guerrini D Beccati Z Shriver A Naggi K Viswanathan A Bisio I Capila JC Lansing S Guglieri B Fraser A Al-Hakim NS Gunay Z Zhang L Robinson L Buhse M Nasr J Woodcock R Langer G Venkataraman RJ Linhardt B Casu G Torri R Sasisekharan 2008 Nat Biotechnol 26 669 675 1:CAS:528:DC%2BD1cXmvVCisrY%3D 10.1038/nbt1407
-
(2008)
Nat Biotechnol
, vol.26
, pp. 669-675
-
-
Guerrini, M.1
Beccati, D.2
Shriver, Z.3
Naggi, A.4
Viswanathan, K.5
Bisio, A.6
Capila, I.7
Lansing, J.C.8
Guglieri, S.9
Fraser, B.10
Al-Hakim, A.11
Gunay, N.S.12
Zhang, Z.13
Robinson, L.14
Buhse, L.15
Nasr, M.16
Woodcock, J.17
Langer, R.18
Venkataraman, G.19
Linhardt, R.J.20
Casu, B.21
Torri, G.22
Sasisekharan, R.23
more..
-
4
-
-
47149108319
-
-
1:CAS:528:DC%2BD1cXns1yntLc%3D 10.2174/138161208784246135
-
S Alban 2008 Curr Pharm Des 14 1152 1175 1:CAS:528:DC%2BD1cXns1yntLc%3D 10.2174/138161208784246135
-
(2008)
Curr Pharm des
, vol.14
, pp. 1152-1175
-
-
Alban, S.1
-
5
-
-
58149471441
-
-
1:CAS:528:DC%2BD1MXisFSitro%3D
-
S Alban 2008 Hamostaseologie 28 400 420 1:CAS:528:DC%2BD1MXisFSitro%3D
-
(2008)
Hamostaseologie
, vol.28
, pp. 400-420
-
-
Alban, S.1
-
6
-
-
44849115945
-
-
1:CAS:528:DC%2BD1cXmvFKmtb4%3D 10.1056/NEJMoa0803200
-
TK Kishimoto K Viswanathan T Ganguly S Elankumaran S Smith K Pelzer JC Lansing N Sriranganathan G Zhao Z Galcheva-Gargova A Al-Hakim GS Bailey B Fraser S Roy T Rogers-Cotrone L Buhse M Whary J Fox M Nasr GJ Dal Pan Z Shriver RS Langer G Venkataraman KF Austen J Woodcock R Sasisekharan 2008 N Engl J Med 358 2457 2467 1:CAS:528:DC%2BD1cXmvFKmtb4%3D 10.1056/NEJMoa0803200
-
(2008)
N Engl J Med
, vol.358
, pp. 2457-2467
-
-
Kishimoto, T.K.1
Viswanathan, K.2
Ganguly, T.3
Elankumaran, S.4
Smith, S.5
Pelzer, K.6
Lansing, J.C.7
Sriranganathan, N.8
Zhao, G.9
Galcheva-Gargova, Z.10
Al-Hakim, A.11
Bailey, G.S.12
Fraser, B.13
Roy, S.14
Rogers-Cotrone, T.15
Buhse, L.16
Whary, M.17
Fox, J.18
Nasr, M.19
Dal Pan, G.J.20
Shriver, Z.21
Langer, R.S.22
Venkataraman, G.23
Austen, K.F.24
Woodcock, J.25
Sasisekharan, R.26
more..
-
8
-
-
79251632746
-
-
N.N. Heparin sodium. Stage 2 (2009) US Pharmacopoeia, Rockville http://www.usp.org/hottopics/heparin.html. Accessed March 05, 2010
-
(2009)
N.N. Heparin Sodium. Stage 2
-
-
-
9
-
-
79251635581
-
-
Accessed June 01, 2010
-
EDQM. Heparin sodium, Monograph 0333 (2010) http://www.edqm.eu/medias/ fichiers/NEW-Heparin-sodium-0820100333.pdf. Accessed June 01, 2010
-
(2010)
Heparin Sodium, Monograph
, vol.333
-
-
-
10
-
-
77749298749
-
-
1:CAS:528:DC%2BC3cXivV2rsbc%3D 10.1038/nbt0310-203
-
J Pan Y Qian X Zhou A Pazandak SB Frazier P Weiser H Lu L Zhang 2010 Nat Biotechnol 28 203 207 1:CAS:528:DC%2BC3cXivV2rsbc%3D 10.1038/nbt0310-203
-
(2010)
Nat Biotechnol
, vol.28
, pp. 203-207
-
-
Pan, J.1
Qian, Y.2
Zhou, X.3
Pazandak, A.4
Frazier, S.B.5
Weiser, P.6
Lu, H.7
Zhang, L.8
-
13
-
-
63149149990
-
-
1:CAS:528:DC%2BD1MXktFamsbs%3D 10.1016/j.ab.2009.02.012
-
N Volpi F Maccari RJ Linhardt 2009 Anal Biochem 388 140 145 1:CAS:528:DC%2BD1MXktFamsbs%3D 10.1016/j.ab.2009.02.012
-
(2009)
Anal Biochem
, vol.388
, pp. 140-145
-
-
Volpi, N.1
MacCari, F.2
Linhardt, R.J.3
-
14
-
-
49749083965
-
-
1:CAS:528:DC%2BD1cXhtVartrfK 10.1016/j.jpba.2008.06.014
-
T Beyer B Diehl G Randel E Humpfer H Schafer M Spraul C Schollmayer U Holzgrabe 2008 J Pharm Biomed Anal 48 13 19 1:CAS:528:DC%2BD1cXhtVartrfK 10.1016/j.jpba.2008.06.014
-
(2008)
J Pharm Biomed Anal
, vol.48
, pp. 13-19
-
-
Beyer, T.1
Diehl, B.2
Randel, G.3
Humpfer, E.4
Schafer, H.5
Spraul, M.6
Schollmayer, C.7
Holzgrabe, U.8
-
16
-
-
64549149399
-
-
1:CAS:528:DC%2BD1MXhs1ajtLg%3D 10.1021/ac802626e
-
P Hu L Fang EK Chess 2009 Anal Chem 81 2332 2343 1:CAS:528: DC%2BD1MXhs1ajtLg%3D 10.1021/ac802626e
-
(2009)
Anal Chem
, vol.81
, pp. 2332-2343
-
-
Hu, P.1
Fang, L.2
Chess, E.K.3
-
18
-
-
58049198198
-
-
1:CAS:528:DC%2BD1cXhsFaqtLjM 10.1056/NEJMc0807070
-
S Alban S Lühn 2008 N Engl J Med 359 2732 2734 1:CAS:528: DC%2BD1cXhsFaqtLjM 10.1056/NEJMc0807070
-
(2008)
N Engl J Med
, vol.359
, pp. 2732-2734
-
-
Alban, S.1
Lühn, S.2
-
19
-
-
58149121309
-
-
1:CAS:528:DC%2BD1cXhtlOiur3K 10.1021/ac801879t
-
L Wang S Buchanan ME Meyerhoff 2008 Anal Chem 80 9845 9847 1:CAS:528:DC%2BD1cXhtlOiur3K 10.1021/ac801879t
-
(2008)
Anal Chem
, vol.80
, pp. 9845-9847
-
-
Wang, L.1
Buchanan, S.2
Meyerhoff, M.E.3
-
22
-
-
34748852521
-
-
1:CAS:528:DC%2BD2sXhtFWktrzE 10.1002/chem.200700677
-
W Sun H Bandmann T Schrader 2007 Chemistry 13 7701 7707 1:CAS:528:DC%2BD2sXhtFWktrzE 10.1002/chem.200700677
-
(2007)
Chemistry
, vol.13
, pp. 7701-7707
-
-
Sun, W.1
Bandmann, H.2
Schrader, T.3
-
25
-
-
69749122095
-
-
1:CAS:528:DC%2BD1MXhtValu7vE 10.1177/1076029609338710
-
C Viskov E Bouley P Hubert C Martinez F Herman W Jeske D Hoppensteadt JM Walenga J Fareed 2009 Clin Appl Thromb Hemost 15 395 401 1:CAS:528: DC%2BD1MXhtValu7vE 10.1177/1076029609338710
-
(2009)
Clin Appl Thromb Hemost
, vol.15
, pp. 395-401
-
-
Viskov, C.1
Bouley, E.2
Hubert, P.3
Martinez, C.4
Herman, F.5
Jeske, W.6
Hoppensteadt, D.7
Walenga, J.M.8
Fareed, J.9
-
27
-
-
33749347624
-
-
1:CAS:528:DC%2BD28XpvFShsbs%3D 10.1158/1078-0432.CCR-05-2423
-
M Basche DL Gustafson SN Holden CL O'Bryant L Gore S Witta MK Schultz M Morrow A Levin BR Creese M Kangas K Roberts T Nguyen K Davis RS Addison JC Moore SG Eckhardt 2006 Clin Cancer Res 12 5471 5480 1:CAS:528:DC%2BD28XpvFShsbs%3D 10.1158/1078-0432.CCR-05-2423
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5471-5480
-
-
Basche, M.1
Gustafson, D.L.2
Holden, S.N.3
O'Bryant, C.L.4
Gore, L.5
Witta, S.6
Schultz, M.K.7
Morrow, M.8
Levin, A.9
Creese, B.R.10
Kangas, M.11
Roberts, K.12
Nguyen, T.13
Davis, K.14
Addison, R.S.15
Moore, J.C.16
Eckhardt, S.G.17
|